Delivery Order SPE2DR25D1106-SPE2DR26FJB9M
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,055.07 for VIVITROL 380 mg vials with diluents on December 2, 2025, with a completion date of December 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $9,750.83 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $12,107.97 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed price, competitively awarded contract was executed on November 12, 2025, with an ultimate completion date of November 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,001.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents, with an ultimate completion date of September 5, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award demonstrates continued federal reliance on AmerisourceBergen as a critical pharmaceutical distributor for military...
- The Defense Logistics Agency (DLA) awarded a $2,002.34 delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. VIVITROL is an extended-release injectable medication used primarily for opioid use disorder treatment, making...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,002.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of June 30, 2025. This non-set-aside award was issued on June 27, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of VIVITROL 380 mg vial-diluents. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, issued on November 24, 2025. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. VIVITROL is an extended-release naltrexone formulation used in opioid use disorder treatment, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $2,208.18 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB9MDelivery Order
The Defense Logistics Agency awarded a $2,110.14 delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 mg vial-diluents on December 3, 2025, with completion scheduled for December 4, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award is issued from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. VIVITROL (naltrexone) is an FDA-approved medication used in opioid use disorder treatment, representing the type of specialized pharmaceutical product that AmerisourceBergen delivers through its federal medical supply contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/2/25 |